J0799 – Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0799
- Long description
- Fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified
- Short description
- Hiv prep, fda approved, noc
- Pricing indicator
46Priced by carrier (not otherwise classified / individual determination)- Medicare coverage
DSpecial coverage instructions apply- BETOS category
O1EOther drugs- Added
- January 2, 2024
- Last change
- January 2, 2024 – No change
Frequently asked questions
What is HCPCS code J0799?
J0799 is a HCPCS Level II code for fda approved prescription drug, only for use as hiv pre-exposure prophylaxis (not for use as treatment of hiv), not otherwise classified.
Does Medicare cover J0799?
The HCPCS file lists coverage code D: Special coverage instructions apply. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0752 – Oral, lenacapavir, 300 mg, fda approved prescription, only for use as hiv pre-exposure prophylaxis (not for use as treatment for hiv)
- J0759 – Injection, clevidipine butyrate, 1 mg
- J0760 – Injection, colchicine, per 1 mg
- J0770 – Injection, colistimethate sodium, up to 150 mg
- J0775 – Injection, collagenase, clostridium histolyticum, 0.01 mg
- J0780 – Injection, prochlorperazine, up to 10 mg
- J0791 – Injection, crizanlizumab-tmca, 5 mg
- J0795 – Injection, corticorelin ovine triflutate, 1 microgram
- J0800 – Injection, corticotropin, up to 40 units
- J0801 – Injection, corticotropin (acthar gel), up to 40 units
- J0802 – Injection, corticotropin (ani), up to 40 units
- J0833 – Injection, cosyntropin, not otherwise specified, 0.25 mg
- J0834 – Injection, cosyntropin, 0.25 mg
- J0840 – Injection, crotalidae polyvalent immune fab (ovine), up to 1 gram
- J0841 – Injection, crotalidae immune f(ab')2 (equine), 120 mg
- J0850 – Injection, cytomegalovirus immune globulin intravenous (human), per vial
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.